Kevin Schwartzman

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

BMJ global health

PLoS medicine

Open forum infectious diseases

BMC public health

McGill University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

McGill University Jul 01 2014

Canada

Full Professor :: Medicine

McGill University Jan 01 2014

Canada

Director, Respiratory Division :: Medicine

Publications

Miranda Zary, Mona Salaheldin Mohamed, Cedric Kafie, Chimweta Ian Chilala, Shruti Bahukudumbi, Nicola Foster, Genevieve Gore, Katherine L Fielding, Ramnath Subbaraman, Kevin Schwartzman
The performance of digital technologies for measuring tuberculosis medication adherence: a systematic review. BMJ global health 9 (7) (2024)
Miranda Zary, Mona Salaheldin Mohamed, Cedric Kafie, Chimweta Ian Chilala, Shruti Bahukudumbi, Nicola Foster, Genevieve Gore, Katherine L Fielding, Ramnath Subbaraman, Kevin Schwartzman
The performance of digital technologies for measuring tuberculosis medication adherence: a systematic review. BMJ global health 9 (7) (2024)
Miranda Zary, Mona Salaheldin Mohamed, Cedric Kafie, Chimweta Ian Chilala, Shruti Bahukudumbi, Nicola Foster, Genevieve Gore, Katherine L Fielding, Ramnath Subbaraman, Kevin Schwartzman
The performance of digital technologies for measuring tuberculosis medication adherence: a systematic review. BMJ global health 9 (7) (2024)
Ntwali Placide Nsengiyumva, Jonathon R Campbell, Saeedeh Moayedi-Nia, Juan F Vesga, Christian Lienhardt, Anete Trajman, Dennis Falzon, Saskia Den Boon, Nimalan Arinaminpathy, Kevin Schwartzman
Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness. PLoS medicine 19 (6) (2022)
Ntwali Placide Nsengiyumva, Hamidah Hussain, Olivia Oxlade, Arman Majidulla, Ahsana Nazish, Aamir J Khan, Dick Menzies, Faiz Ahmad Khan, Kevin Schwartzman
Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence-Based Chest Radiograph Interpretation: A Cost-Effectiveness Analysis. Open forum infectious diseases 8 (12) (2021)
Aashna Uppal, Olivia Oxlade, Ntwali Placide Nsengiyumva, Dieynaba S N'Diaye, Gonzalo G Alvarez, Kevin Schwartzman
Social and behavioral risk reduction strategies for tuberculosis prevention in Canadian Inuit communities: a cost-effectiveness analysis. BMC public health 21 (1) (2021)
Christopher Pease, Gonzalo Alvarez, Ranjeeta Mallick, Mike Patterson, Sandy Finn, Yahya Habis, Kevin Schwartzman, Elaine Kilabuk, Sunita Mulpuru, Alice Zwerling
Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting. BMJ open 11 (5) (2021)
Lisa A Ronald, J Mark FitzGerald, Gillian Bartlett-Esquilant, Kevin Schwartzman, Andrea Benedetti, Jean-François Boivin, Dick Menzies
Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs. The European respiratory journal 55 (3) (2020)
Dieynaba S N'Diaye, Ntwali Placide Nsengiyumva, Aashna Uppal, Olivia Oxlade, Gonzalo G Alvarez, Kevin Schwartzman
The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities. BMC medicine 17 (1) (2019)
Jonathon R Campbell, David Dowdy, Kevin Schwartzman
Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries. PLoS medicine 16 (6) (2019)

Kevin Schwartzman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kevin Schwartzman